Catalyst Wire Dossier Catalyst Wire Dossier

Oculeve Intranasal Lacrimal Neurostimulator

· Oculeve, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Oculeve Intranasal Lacrimal Neurostimulator, covering 2019-04-26 to 2020-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye [NA]

See pricing